Analysis of factors influencing the distribution of 131-I in combined treatment of Licartin with transcatheter arterial chemoembolization in primary hepatic carcinoma

OBJECTIVE: To analyze the factors influencing the distribution of 131-I in the liver of patients with advanced hepatic carcinoma treated with the combination of Licartin ((131)I Metuximab) and transcatheter arterial chemoembolization (TACE). This study provides a reference and basis for the clinic o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Ming, Li, Wen-Liang, Li, Jia-Yu, Lv, Juan, Chen, Fu-Kun, Zhu, Jia-Lun, Liu, Peng-Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040873/
https://www.ncbi.nlm.nih.gov/pubmed/36994225
http://dx.doi.org/10.3389/fonc.2022.993948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040873/
https://www.ncbi.nlm.nih.gov/pubmed/36994225
http://dx.doi.org/10.3389/fonc.2022.993948

Ejemplares similares